Intracellular Calcium Mobilization as a Target for the Spasmolytic Action of Scopoletin

Abstract

The coumarin scopoletin was isolated in a pure form from the roots of Brunfelsia hopeana Benth. (Solanaceae). In isolated rat aortic rings, scopoletin (26-520 μM) inhibited to approximately the same extent the contractions induced by a variety of substances, including phenylephrine, potassium chloride, serotonin and PGF_{2 α}. The effect of the coumarin on phenylephrine-induced contractions was not affected by endothelium removal or NO-synthase blockade by L-NAME (100 μM). Scopoletin (78 - 590 μM) antagonized in a concentration-dependent manner (IC₅₀ = 300 ± 20 μM, n = 5), transient contractions in Ca²⁺-free media induced by noradrenaline, but not those induced by caffeine. Also, scopoletin did not interfere with the refilling of noradrenaline-sensitive intracellular calcium stores. It is suggested that the non-specific spasmolytic action of scopoletin can be attributed, at least in part, to its ability to inhibit the intracellular calcium mobilization from the noradrenaline-sensitive stores.

Brunfelsia hopeana - Solanaceae - scopoletin - intracellular calcium - spasmolytic actions - rat aorta

References

• 1 Ojewole J A, Adesina S K. Cardiovascular and neuromuscular actions of scopoletin from fruit Tetrapleura tetraptera .  Planta Medica. 1983;  49 99-102
• 2 Ojewole J A, Adesina S K. Mechanism of the hypotensive effect of scopoletin isolates from the fruit of Tetrapleura tetraptera .  Planta Medica. 1983;  49 46-50
• 3 Reinecke M G, Minter D E, Jia Q. Carbon and proton NMR assignments for 6,7-dimethoxycoumarin.  Magnetic Resonance in Chemistry. 1995;  33 757-8
• 4 Altura B M., Altura B T. Differential effects of substrate on drug-induced contactions of rabbit aorta.  American Journal of Physiology. 1970;  219 1698-705
• 5 Sakata K, Karaki H. Effects of a novel smooth muscle relaxant, KT-362, on contraction and cytosolic Ca²⁺ level in the rat aorta.  British Journal of Pharmacology. 1991;  102 174-8
• 6 Nelson M T, Patlak J B, Worley J F, Standen N B. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone.  American Journal of Physiology (1 Pt 1). 1990;  259 3-18
• 7 Karaki H, Weiss G B. Calcium release in smooth muscle.  Life Sciences. 1988;  42 111-22
• 8 Gurney A M. Mechanisms of drug-induced vasodilation.  Journal of Pharmacy and Pharmacology. 1994;  46 (4) 242-51
• 9 Nasa Y, Ichihara K, Yoshida R, Abiko Y. Positive inotropic and negative chronotropic effects of (-)-cis-diltiazem in rat isolated atria.  British Journal of Pharmacology. 1992;  105 (3) 696-702
• 10 Karaki H, Ozaki H, Hori M, Mitsui-Saito M, Amano K, Harada K, Miyamoto S, Nakazawa H, Won K J, Sato K. Calcium movements, distribution, and functions in smooth muscle.  Pharmacological Reviews. 1997;  49 157-230
• 11 Clapham D E. Calcium signaling.  Cell. 1995;  80 259-68
• 12 Bootman M D, Berridge M J. The elemental principles of calcium signaling.  Cell. 1995;  83 675-8
• 13 Moncada S, Palmer R MJ, Higgs E A. Nitric oxide: Physiology, pathophysiology and pharmacology.  Pharmacological Reviews. 1991;  43 109-42
• 14 Moncada S, Higgs E A. The L-arginine-nitric oxide pathway.  New England Journal of Medicine . 1993;  29 2002-12